Abstract:Background: COVID-19, caused by SARS-CoV-2 infection, has recently been announced as a pandemic all over the world. Remarkable achievements have been made in diagnosis, prevention and treatment of COVID-19 from clinical studies. However, animal models, particularly non-human primate models, are urgently needed for critical questions that could not be answered in clinical patients, evaluations of anti-viral drugs and vaccines. Methods: Two families of three species of non-human primates (NHP), old world monkeys (Macaca mulatta, Macaca fascicularis) and new world monkeys (Callithrix jacchus), were experimentally inoculated with SARS-CoV-2. Clinical signs were recorded. Samples were collected for analysis of viral shedding, viremia and evaluation of host responses to SARS-CoV-2 infection. Findings: Increased body temperature was observed in M. mulatta and M. fascicularis, but not C. jacchus post inoculation of SARS-CoV-2. All of M. mulatta and M. fascicularis showed chest radiographic abnormality. Viral genomes were detected in swab samples and blood from all 3 species of monkeys. Viral shedding from upper respiratory reached the peak between day 6 and day 8 post inoculation. Viruses were mainly detected in lung, weasand, bronchus and spleen of M. mulatta and M. fascicularis, but not C. jacchus. M. mulatta showed stronger cytokine responses to SARS-CoV-2 infection than M. fascicularis. Severe gross lesions and histopathological changes were observed mainly in lung and secondary lymphoid of SARS-CoV-2 infected M. mulatta and M. fascicularis. The susceptibility to SARS-CoV2 infection is M. mulatta > M. fascicularis > C. jacchus. Interpretations: We have established a NHP model for COVID-19, which recapitulates several important aspects of COVID-19 patients and could be used to evaluate anti-viral drugs and vaccines, and investigate viral pathogenesis.Funding Statement: This study was supported by 2020YFC0841100 and 2020YFC0846400. Declaration of Interests: None.Ethics Approval Statement: All animal procedures were approved by the Institutional Animal Care and Use Committee of Institute of Medical Biology, Chinese Academy of Medical Science (Ethics number: DWSP202002 001), and performed in the ABSL-4 facility of National Kunming High-level Biosafety Primate Research Center, Yunnan China.

Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2

Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model

Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques

Simian Human Immunodeficiency Virus-Associated Pneumonia Correlates with Increased Expression of MCP-1, CXCL10, and Viral RNA in the Lungs of Rhesus Macaques

Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in <i>Rhesus macaques</i>

Age‐related rhesus macaque models of COVID‐19

SARS-CoV-2 Omicron (B.1.1.529) Infection in Rhesus Macaques, Hamsters, and BALB/c Mice with Severe Lung Histopathological Damage.

Compartmentalized SARS-CoV-2 replication in upper versus lower respiratory tract after intranasal inoculation or aerosol exposure

Intratracheal Inoculation of Severe Acute Respiratory Syndrome Coronavirus in Monkeys Macaca Rhesus

Aerosol Exposure of Cynomolgus Macaques to SARS-CoV-2 Results in More Severe Pathology than Existing Models

Single-nucleus Transcriptomic Profiling of Multiple Organs in a Rhesus Macaque Model of SARS-CoV-2 Infection

Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2

Differential Transcriptomic Landscapes of SARS-CoV-2 Variants in Multiple Organs from Infected Rhesus Macaques

Reinfection could not occur in SARS-CoV-2 infected rhesus macaques

Northern Pig-Tailed Macaques (macaca Leonina) Infected with SARS-CoV-2 Show Rapid Viral Clearance and Persistent Immune Response

Comparison of SARS-CoV-2 Infections Among Three Species of Non-Human Primates

Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques

Comparison of SARS-CoV-2 infections among 3 species of non-human primates

Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques

SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts

An Animal Model of Mers Produced by Infection of Rhesus Macaques with Mers Coronavirus